Ranking of Increasing Margin Buying Positions in Japan

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Stock	Price	Change	Volume	Margin Ratio	Buy Positions(Shares)	Weekly Change	Market Cap	Liquidity
Globalway 3936 TSE Growth	176	-10 -5.4%	2,088,400	1,180.47	5,076,000	+2,401,700	6.44B	High
OncoTherapy Science 4564 TSE Growth	23	-1 -4.2%	179,113,400	7.64	20,477,300	+2,039,800	8.82B	Mid
BrightPath Biotherapeutics 4594 TSE Growth	59	+4 +7.27%	8,884,400	14.26	20,760,300	+1,414,900	8.19B	Slightly High
MEDINET 2370 TSE Growth	28	0 ー%	240,900	0.00	13,161,900	+678,500	7.77B	Mid
Modalis Therapeutics 4883 TSE Growth	66	-14 -18%	14,371,300	0.00	10,974,900	+657,900	6.1B	Mid
iShares AI Active 408A TSE ETF	279.3	+3.8 +1.38%	551,140	0.00	1,143,359	+547,409	6.56B	Mid
TAY TWO 7610 TSE Standard	139	-1 -0.7%	587,700	65.22	5,446,100	+477,600	9.54B	Mid
SystemSoft 7527 TSE Standard	52	0 ー%	1,375,500	0.00	9,415,400	+390,300	5.5B	Mid
VALUENEX Japan 4422 TSE Growth	1,014	-42 -4.0%	598,700	0.00	579,000	+280,300	8.84B	Slightly High
Wel-Dish 2901 TSE Standard	191	-4 -2.1%	470,200	0.00	1,332,100	+217,700	5.46B	Mid
ALMEDIO 7859 TSE Standard	273	-4 -1.4%	271,400	4.74	3,993,200	+214,100	5.68B	Slightly High
Asterisk 6522 TSE Growth	1,182	+41 +3.59%	982,300	30.13	1,099,700	+197,300	9.5B	High
D.Western Therapeutics Institute 4576 TSE Growth	91	+1 +1.11%	65,100	0.00	5,750,800	+193,200	5.19B	Slightly High
New Japan Chemical 4406 TSE Standard	202	+12 +6.32%	638,400	13.86	1,608,900	+171,800	7.53B	Mid
VELTRA 7048 TSE Growth	162	+2 +1.25%	75,600	2.31	1,136,500	+154,800	5.93B	Mid
RIVER ELETEC 6666 TSE Standard	1,009	-22 -2.1%	227,000	0.00	776,700	+152,200	8.77B	Slightly High
Star seeds 3083 TSE Standard	1,152	+52 +4.73%	224,700	13,631.00	2,726,200	+150,200	9.94B	Slightly High
Chiome Bioscience 4583 TSE Growth	101	+1 +1.00%	767,600	0.00	6,382,500	+148,600	7.34B	Mid
Sanoyas Holdings 7022 TSE Standard	293	-17 -5.5%	210,500	43.20	769,000	+146,800	9.96B	Mid
SymBio Pharma 4582 TSE Growth	90	-2 -2.2%	743,600	0.00	6,171,800	+137,700	6.5B	Slightly High

About:

Liquidity

Liquidity Grade

Liquidity	1-Year Average Number of Trades	Distribution
High	Over 1,000	13.9%
Slightly-High	400 to 1,000	18.5%
Mid	50 to 400	39.0%
Slightly-Low	10 to 50	17.6%
Low	Less than 10	11.0%

Labels